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Summary 
 
This article explores the challenges associated with diagnosing and managing eating disorders such 
as anorexia nervosa amongst adolescents and adults with cystic fibrosis. It reviews the known risk 
factors, generic verses disease specific eating disorder risk screening tools and considers the ethical 
dilemmas associated with critically low body mass indices. A case review is included to illustrate the 
complexities of managing both conditions in the context of declining respiratory function. 
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Introduction 
 
The association between good nutritional status and improved health outcomes in cystic fibrosis (CF) 
is firmly established (1). It is achieved by regular dietetic review to encourage high calorie diet, 
adequate pancreatic enzyme replacement, alongside early intervention and investigation of weight 
loss. The co-existing diagnosis of an eating disorder in CF has the potential to hasten respiratory 
decline as a consequence of malnutrition.  
 
Case review 
 
This 20 year old lady was diagnosed with CF age 2years 11months on a background of recurrent 
respiratory tract infections. She is homozygous for the Phe508del mutation, has osteopenia, CF 
related diabetes (CFRD), and chronic Pseudomonas aeruginosa and Achromobacter xylosoxidans 
colonisation. She also has a history of bilateral sensorineural hearing loss secondary to meningitis at 
age 6 weeks and took a paracetamol overdose age 14 years. On transition to the adult service her 
forced expiratory volume in one second (FEV1) was between 40 to 50% with a Body Mass Index 
(BMI) of 21, which had started to drift downwards from the age of 15 years. She has a heavy 
treatment burden and frequent admissions to hospital with worsening lung function requiring long 
term oxygen therapy and nocturnal non invasive ventilation (figure 1). In the previous year she had 
153 days of intravenous antibiotics. She found it very difficult to accept her declining health. The 
only thing which she felt able to control was her weight. She was diagnosed with anorexia nervosa 
age 19 years with a BMI of 17.8 kg/m2. Her disordered eating behaviours include diet restriction, 
variable compliance with pancreatic enzyme supplementation and daily body checking. Her body 
image is distorted as she believes there is no problem with her weight.  
 
Her BMI fell to 14.8 in April 2015(figure 2). At that point she had been deemed to lack capacity so 
could have been detained under the Mental Health Act but agreed to voluntary transfer to the 
Eating Disorders Unit. She stayed for eight months in the Eating Disorders Unit, with intermittent 
readmissions to hospital for treatment of pulmonary exacerbations. On discharge from the unit her 
BMI was 15.2 and her FEV1 remained below 30%. She had gained under one kilogram during that 
period. She has ongoing input from the community eating disorders team. She had declined enteral 
feeding until six months ago when she attempted an overnight feed but only tolerated the 
nasogastric tube for 2.5 hours.  
 
Her glycaemic control has been poor which may be representative of disease progression and 
frequent infections. It is also a result of insulin omission which may be a direct attempt to 
manipulate her weight. The CF team has systematically tried to optimise all of her care. For example 
using tally charts and I-neb downloads to work on her adherence and at her best this reached 100%. 
She has had regular home visits and outpatient reviews with the multidisciplinary team, which 
includes a dedicated CF psychologist and diabetologist. She has recently commenced 
Ivacaftor/lumacaftor. 
 
She would like to improve her BMI in order to be referred for a lung transplant. The eating disorders 
and CF teams acknowledge that it can take years to successfully treat anorexia nervosa. Her current 
BMI precludes her from referral for lung transplant. Without a timely improvement in her BMI she 
may miss the opportunity to be considered for lung transplantation.  
 
Discussion 
 
Anorexia nervosa has the highest mortality amongst psychiatric disorders at three times greater 
than all other conditions. It is multifactorial in origin and is associated with obsessive, perfectionist 
and competitive traits. It can also be triggered as a coping mechanism (2). On average it takes five or 
six years for complete recovery. A third of patients may never recover although there have been 
reports of recovery 21 years after diagnosis. Anorexia nervosa affects 1 in 250 females and 1 in 2000 
males, with a peak incidence occurring in late adolescence and early twenties. Poorer outcomes are 
associated with a presentation between 20 and 29 years and lower weights. 
 
How can we identify, manage and monitor CF patients at risk of developing eating disorders? 
 
The structure of CF care means patients receive regular clinical review providing an opportunity to 
monitor BMI and eating patterns. Eating disorders must be considered as a potential cause for 
unexplained weight loss. Risk factors for developing eating disorders include factors which may be a 
direct consequence of severe CF disease such as delayed growth and puberty, low body weight, 
comorbidities such as CFRD, preoccupation with disease and dietary management, as well as 
reduced life expectancy. Whereas other risk factors such as social isolation, low self esteem and 
body image disturbance may be related to external influences or as a result of CF(3).  
 
It has been observed that with a declining nutritional status, the perception of body image becomes 
an increasing concern for adults with CF (4). There are also non eating-related factors such as 
clubbing or medicalisation of the person by the insertion of a porta Cath, which can also negatively 
impact on body image (5). 
 
Generic screening tools for eating disorders can be inadequate in the context of CF. Some of the 
measures of disturbed eating attitudes and behaviours may simply reflect the impact of the 
condition or its management, for example a preoccupation with food due to dietary 
recommendations (6, 7, 8). Disordered eating behaviours can exist without the diagnosis of an eating 
disorder and early recognition of these patterns helps identify those at greater risk. Generic 
measures fail to assess for disease specific eating attitudes and behaviours such as those related to 
poor nutritional status, for example feeling full easily. Therefore, a CF specific screening tool has 
been developed to identify these behaviours, which include omitting pancreatic enzymes or insulin 
in order to control weight. (5) 
 
It might appear that there should be a greater incidence of eating disorders amongst the CF 
population given the continued emphasis on the attainment of optimal BMI; however the evidence 
is inconclusive (6). In general, adolescents with chronic illnesses that have a dietary component have 
been found to be at increased risk for developing eating disorders or disordered eating behaviour 
compared to their peers (6). However, with respect to CF there is some work which demonstrates 
adolescents and young adults with CF have eating behaviour and attitudes, body satisfaction and 
self-esteem, similar to healthy controls. There is a suggestion that females with CF actually have 
fewer problems (5). 
 
It seems within a subset of CF patients there is evidence of an increase in risk factors and disordered 
eating behaviours. In CFRD, particularly females, there are increased concerns around eating 
behaviours as well as dissatisfaction with body appearance and low self-esteem. Unsurprisingly 
adults requiring enteral tube feeding have issues related to body image, self-esteem and have a 
poorer quality of life. NICE guidance recommends screening for eating disorders in young people 
with type 1 diabetes and poor treatment adherence so there may be a role for a similar targeted 
approach within CFRD (9).  
 
The presence of risk factors for eating disorders and disordered eating behaviours identifies those 
who warrant psychological assessment or closer monitoring. Some of these indicators may be 
caused by the psychological consequences of treatment burden, disease progression and 
medicalisation of the body. It may also be that disordered eating behaviours may actually represent 
attentive and self-regulated eating which helps maintain optimal BMIs (10). 
 
What are the ethical dilemmas of managing critically low BMIs in the context of CF and anorexia 
nervosa?  
 
Poor nutritional status and low BMI have a significant impact on physical health and in the setting of 
severe lung disease can be ultimately life threatening. This is a result of respiratory muscle weakness 
and increased energy requirements. In the context of anorexia nervosa, discussing the risks 
associated with low weight and respiratory failure does not lead to behaviour change. It is likely that 
the individual will disregard the significance of such risk, given that ambivalence is an inherent 
feature of anorexia nervosa. The dilemma in the context of anorexia nervosa and severe respiratory 
disease is that a BMI below 14 kg/m2 has a far more significant impact on physical health than in 
those without additional comorbidity. Mental Health Act Assessments, to determine capacity, are 
typically considered when BMIs fall below 14 but in the context of declining physical health this 
would need to take place sooner.  
 
Without capacity, an individual could be detainable under the Mental Health Act, in order to initiate 
inpatient treatment for an eating disorder. This is usually only considered as a last resort as it is so 
restrictive and likely to impact on future therapeutic relationships. Nasogastric tube feeding is not 
standard practice in eating disorder care and it would only be considered if someone was refusing all 
oral intake or rapidly declining in weight. Logistically this is difficult to enforce when an individual is 
physically resistant and feeding against the will of a patient requires legal consideration. This 
contrasts with the nutritional recommendations in CF where enteral feeding is considered if despite 
supplementation BMI remains below 20 kg/m2 or there is ongoing weight loss (11, 12).  
 
Reviewing the literature (9), there are mixed outcomes for compulsory admission. Potential benefits 
include: weight gain, reduction in morbidity and mortality, improvement in mood, concentration and 
symptoms, and reduced cognitive impairment. The potential risks include: barrier to formation of a 
therapeutic relationship, negative physical and psychological impact, negative countertransference, 
stigma associated with the Mental Health Act, loss of self- esteem and escalation of resistance. 
 
Cognitive function is impaired by low weight and anorexia nervosa. Usually this improves with 
weight restoration but in some cases it may not fully recover. This is an important consideration in 
the management of patients both during and after recovery from an eating disorder and also in CF 
patients malnourished from other causes. 
 
How do you support patients and the multidisciplinary team to set realistic goals and 
expectations?  
 
It is essential to maintain a consistent approach across the CF multidisciplinary team, psychiatric 
community teams and eating disorder units. This might involve regular communication through 
professional meetings to discuss the best interests of the patient. In order to facilitate admission to 
an eating disorders unit, the CF team can provide support and training in specialised respiratory care 
such as physiotherapy, non invasive ventilation and oxygen. During hospital admissions the eating 
disorder team may visit or liaise with the CF unit to provide ongoing support. The first target for 
eating disorders is to achieve weight stability. The primary objective of the eating disorders team is 
to provide a psychological intervention and the duration of treatment and follow up may last years. 
Weight gain can occur sometime after this has been completed. This is challenging for the CF team 
as they strive to provide holistic care. The presence of an active eating disorder precludes weight 
gain and low BMI is a contraindication for lung transplant referral. Therefore, the clinical approach 
needs to adapt to incorporate the limitations an eating disorder has on disease management, in 
particular with regard to enteral feeding.  
 
Discordance between patient goals and health related behaviours is a feature of nonadherence and 
can be seen within eating disorders. It is reported that 50% of medications prescribed for chronic 
illness are not taken as directed and this can vary with individuals over time (13). It is important to 
understand this, utilise objective measures and provide ongoing support to enable patients to 
maintain or improve adherence. 
 
Conclusion 
 
In CF there are complex interactions between health status and psychosocial influences and it 
remains unclear the extent to which these may be associated with the development of anorexia 
nervosa (7). It is evident that the impact of weight loss in this condition is far more significant than in 
the healthy population. It is therefore important to consider eating disorders in patients with CF who 
have unexplained weight loss to ensure early identification and psychological assessment, 
particularly given the prolonged recovery time for this condition.   
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